glp-1 drug market size Size, Scope, Forecast Report 2026 to 2035 GLP-1 Drugs Market Size to

Differential processing of proglucagon by the subtilisin-like prohormone convertases PC2 and PC3 to generate either glucagon or glucagon-like peptide

Oral GLP-1 RAs are also under development, and early data show similar weight loss efficacy to semaglutide 2.4 mg [84], which could improve convenience and potentially reduce costs through improved manufacturing and distribution efficiency

GLP-1 Receptor Agonist Market Size and Trends Forecast: 2026 - 2033 GLP-1 receptor agonist market is estimated to be valued at USD 31.71 Bn in 2026 and is expected to reach USD 72.33 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 12.5% from 2026 to 2033

[DOI] [PubMed] [Google Scholar] 9.Filippatos T, Milionis HJ

doi: 10.3389/FENDO.2021.721135/XML/NLM 7 HolstJJ

Emerging Safety Concerns Recent research has identified new safety considerations beyond traditional gastrointestinal effects